Co-administration of Anti microRNA-124 and -137 Oligonucleotides Prevents Hippocampal Neural Stem Cell Loss Upon Non-convulsive Seizures.
adult hippocampal neurogenesis
kainic acid
microRNA
neural stem cell fate
non-convulsive seizures
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2019
2019
Historique:
received:
28
08
2018
accepted:
24
01
2019
entrez:
7
3
2019
pubmed:
7
3
2019
medline:
7
3
2019
Statut:
epublish
Résumé
Convulsive seizures promote adult hippocampal neurogenesis (AHN) through a transient activation of neural stem/progenitor cells (NSPCs) in the subgranular zone (SGZ) of the dentate gyrus (DG). However, in a significant population of epilepsy patients, non-convulsive seizures (ncSZ) are observed. The response of NSPCs to non-convulsive seizure induction has not been characterized before. We here studied first the short-term effects of controlled seizure induction on NSPCs fate and identity. We induced seizures of controlled intensity by intrahippocampally injecting increasing doses of the chemoconvulsant kainic acid (KA) and analyzed their effect on subdural EEG recordings, hippocampal structure, NSPC proliferation and the number and location of immature neurons shortly after seizure onset. After establishing a KA dose that elicits ncSZ, we then analyzed the effects of ncSZ on NSPC proliferation and NSC identity in the hippocampus. ncSZ specifically triggered neuroblast proliferation, but did not induce proliferation of NSPCs in the SGZ, 3 days post seizure onset. However, ncSZ induced significant changes in NSPC composition in the hippocampus, including the generation of reactive NSCs. Interestingly, intrahippocampal injection of a combination of two anti microRNA oligonucleotides targeting microRNA-124 and -137 normalized neuroblast proliferation and prevented NSC loss in the DG upon ncSZ. Our results show for the first time that ncSZ induce significant changes in neuroblast proliferation and NSC composition. Simultaneous antagonism of both microRNA-124 and -137 rescued seizure-induced alterations in NSPC, supporting their coordinated action in the regulation of NSC fate and proliferation and their potential for future seizure therapies.
Identifiants
pubmed: 30837840
doi: 10.3389/fnmol.2019.00031
pmc: PMC6389789
doi:
Types de publication
Journal Article
Langues
eng
Pagination
31Références
Neuroscience. 1999 Mar;89(3):717-29
pubmed: 10199607
J Neurosci. 1999 Jun 1;19(11):4314-24
pubmed: 10341235
Neurology. 2001 Jul 24;57(2):200-6
pubmed: 11468303
Annu Rev Neurosci. 2002;25:471-90
pubmed: 12052917
Epilepsy Behav. 2000 Oct;1(5):301-14
pubmed: 12609161
J Comp Neurol. 2004 Feb 9;469(3):311-24
pubmed: 14730584
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Neurobiol Dis. 2004 Mar;15(2):196-205
pubmed: 15006689
Trends Neurosci. 2004 Aug;27(8):447-52
pubmed: 15271491
Ann Neurol. 2005 Aug;58(2):211-23
pubmed: 16049933
Exp Neurol. 2005 Dec;196(2):342-51
pubmed: 16168988
Gene Ther. 2006 Mar;13(6):496-502
pubmed: 16195701
Ann Neurol. 2006 Jan;59(1):81-91
pubmed: 16261566
J Neurosci. 2006 Apr 26;26(17):4701-13
pubmed: 16641251
J Neurosci. 2007 Aug 29;27(35):9400-7
pubmed: 17728453
Nat Clin Pract Neurol. 2007 Sep;3(9):505-16
pubmed: 17805245
Epilepsia. 2007;48 Suppl 8:82-4
pubmed: 18330009
Epilepsia. 2008 Jun;49 Suppl 5:26-41
pubmed: 18522598
Seizure. 2009 Jan;18(1):38-42
pubmed: 18755608
Cell Stem Cell. 2010 May 7;6(5):445-56
pubmed: 20452319
J Neurosci. 2010 May 12;30(19):6635-45
pubmed: 20463226
Development. 2010 Sep;137(18):2981-7
pubmed: 20685734
Cell Stem Cell. 2011 May 6;8(5):566-79
pubmed: 21549330
Epilepsy Res. 2012 Feb;98(2-3):206-15
pubmed: 22014748
Front Neurosci. 2012 Feb 17;6:25
pubmed: 22363255
Nat Rev Genet. 2012 Mar 13;13(4):271-82
pubmed: 22411466
Methods Mol Biol. 2012;928:185-95
pubmed: 22956143
Eur J Neurosci. 2012 Dec;36(12):3643-52
pubmed: 22978624
Epilepsia. 2012 Nov;53(11):1917-27
pubmed: 22998690
Neuron. 2012 Sep 20;75(6):1022-34
pubmed: 22998871
Stem Cells Transl Med. 2013 Mar;2(3):185-98
pubmed: 23417642
Mol Ther Nucleic Acids. 2013 Aug 27;2:e117
pubmed: 23982190
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2887-99
pubmed: 24184743
Eur J Neurosci. 2014 Jan;39(1):1-11
pubmed: 24387591
Cell Mol Life Sci. 2014 Aug;71(16):2975-95
pubmed: 24519472
Nat Rev Drug Discov. 2014 Aug;13(8):622-38
pubmed: 25011539
Cell Death Differ. 2015 Jan;22(1):22-33
pubmed: 25190144
J Neurosci. 2015 Feb 25;35(8):3330-45
pubmed: 25716834
Nat Commun. 2015 Mar 26;6:6606
pubmed: 25808087
Neuropharmacology. 2015 Aug;95:234-42
pubmed: 25839899
Cell Stem Cell. 2015 May 7;16(5):488-503
pubmed: 25957904
Sci Rep. 2015 Jul 24;5:12448
pubmed: 26207921
Epilepsia. 2015 Oct;56(10):1515-23
pubmed: 26336950
Stem Cells. 2016 Jan;34(1):220-32
pubmed: 26369286
Stem Cells. 2016 Apr;34(4):997-1010
pubmed: 26729510
eNeuro. 2016 Jan 09;2(6):null
pubmed: 26756038
PLoS Biol. 2016 May 26;14(5):e1002466
pubmed: 27228556
Sci Data. 2016 Aug 16;3:160068
pubmed: 27529540
Curr Opin Neurobiol. 2017 Feb;42:68-74
pubmed: 27978480
Epilepsia. 2017 Feb;58(2):222-230
pubmed: 28157273
Mol Ther Nucleic Acids. 2017 Mar 17;6:45-56
pubmed: 28325299
Stem Cell Reports. 2017 Apr 11;8(4):1046-1061
pubmed: 28330621
Front Neurosci. 2017 Mar 29;11:160
pubmed: 28405182
Hippocampus. 2017 Aug;27(8):839-844
pubmed: 28558121
Hippocampus. 2017 Oct;27(10):1054-1068
pubmed: 28608989
Adv Drug Deliv Rev. 2017 Oct 1;120:118-132
pubmed: 28751200
Epilepsia. 2018 May;59(5):945-958
pubmed: 29637555
Brain Plast. 2017 Nov 9;3(1):43-59
pubmed: 29765859
Front Mol Neurosci. 2018 Dec 11;11:442
pubmed: 30618601
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
pubmed: 4110397
J Neurosci. 1997 May 15;17(10):3727-38
pubmed: 9133393